Lilly, Novo Nordisk near White House deals on obesity drug prices, Endpoints News reports – Reuters

  1. Lilly, Novo Nordisk near White House deals on obesity drug prices, Endpoints News reports  Reuters
  2. Lilly and Novo near White House deal on obesity drug prices  Endpoints News
  3. Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried?  The Motley Fool
  4. Lilly and Novo near White House deal on obesity drug prices – Endpoints News  StreetInsider
  5. Novo Nordisk, Lilly nearing deal on obesity drug pricing, says UBS  TipRanks

Continue Reading